These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2375783

  • 1. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein.
    Jialal I, Vega GL, Grundy SM.
    Atherosclerosis; 1990 Jun; 82(3):185-91. PubMed ID: 2375783
    [Abstract] [Full Text] [Related]

  • 2. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
    Jialal I, Grundy SM.
    J Clin Invest; 1991 Feb; 87(2):597-601. PubMed ID: 1991843
    [Abstract] [Full Text] [Related]

  • 3. A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: evidence for interference with some assays of lipoprotein oxidation by aminoguanidine.
    Scaccini C, Chiesa G, Jialal I.
    J Lipid Res; 1994 Jun; 35(6):1085-92. PubMed ID: 8077847
    [Abstract] [Full Text] [Related]

  • 4. Oxidative modification and antioxidant protection of human low density lipoprotein at high and low oxygen partial pressures.
    Hatta A, Frei B.
    J Lipid Res; 1995 Nov; 36(11):2383-93. PubMed ID: 8656076
    [Abstract] [Full Text] [Related]

  • 5. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions.
    Retsky KL, Freeman MW, Frei B.
    J Biol Chem; 1993 Jan 15; 268(2):1304-9. PubMed ID: 8419332
    [Abstract] [Full Text] [Related]

  • 6. Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue.
    Iuliano L, Pedersen JZ, Camastra C, Bello V, Ceccarelli S, Violi F.
    Free Radic Biol Med; 1999 Apr 15; 26(7-8):858-68. PubMed ID: 10232829
    [Abstract] [Full Text] [Related]

  • 7. The effects of ascorbate and dehydroascorbate on the oxidation of low-density lipoprotein.
    Stait SE, Leake DS.
    Biochem J; 1996 Dec 01; 320 ( Pt 2)(Pt 2):373-81. PubMed ID: 8973543
    [Abstract] [Full Text] [Related]

  • 8. Alpha-tocopherol consumption during low-density-lipoprotein oxidation.
    Jessup W, Rankin SM, De Whalley CV, Hoult JR, Scott J, Leake DS.
    Biochem J; 1990 Jan 15; 265(2):399-405. PubMed ID: 2302177
    [Abstract] [Full Text] [Related]

  • 9. Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein.
    Kontush A, Finckh B, Karten B, Kohlschütter A, Beisiegel U.
    J Lipid Res; 1996 Jul 15; 37(7):1436-48. PubMed ID: 8827516
    [Abstract] [Full Text] [Related]

  • 10. 3-Hydroxyanthranilic acid is an efficient, cell-derived co-antioxidant for alpha-tocopherol, inhibiting human low density lipoprotein and plasma lipid peroxidation.
    Thomas SR, Witting PK, Stocker R.
    J Biol Chem; 1996 Dec 20; 271(51):32714-21. PubMed ID: 8955104
    [Abstract] [Full Text] [Related]

  • 11. beta-Carotene inhibits the oxidative modification of low-density lipoprotein.
    Jialal I, Norkus EP, Cristol L, Grundy SM.
    Biochim Biophys Acta; 1991 Oct 15; 1086(1):134-8. PubMed ID: 1954240
    [Abstract] [Full Text] [Related]

  • 12. Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.
    Jialal I, Grundy SM.
    Circulation; 1993 Dec 15; 88(6):2780-6. PubMed ID: 8252691
    [Abstract] [Full Text] [Related]

  • 13. Ascorbic acid can either increase or decrease low density lipoprotein modification.
    Stait SE, Leake DS.
    FEBS Lett; 1994 Mar 21; 341(2-3):263-7. PubMed ID: 8137950
    [Abstract] [Full Text] [Related]

  • 14. The effects of vitamin C and urate on the oxidation kinetics of human low-density lipoprotein.
    Ma YS, Stone WL, LeClair IO.
    Proc Soc Exp Biol Med; 1994 May 21; 206(1):53-9. PubMed ID: 8183962
    [Abstract] [Full Text] [Related]

  • 15. Ascorbic acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein formation.
    Hwang J, Peterson H, Hodis HN, Choi B, Sevanian A.
    Atherosclerosis; 2000 Jun 21; 150(2):275-84. PubMed ID: 10856519
    [Abstract] [Full Text] [Related]

  • 16. Synergistic interaction between the probucol phenoxyl radical and ascorbic acid in inhibiting the oxidation of low density lipoprotein.
    Kalyanaraman B, Darley-Usmar VM, Wood J, Joseph J, Parthasarathy S.
    J Biol Chem; 1992 Apr 05; 267(10):6789-95. PubMed ID: 1313022
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interactive effects of polyphenols, tocopherol and ascorbic acid on the Cu2+-mediated oxidative modification of human low density lipoproteins.
    Yeomans VC, Linseisen J, Wolfram G.
    Eur J Nutr; 2005 Oct 05; 44(7):422-8. PubMed ID: 15827683
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.